Seres Therapeutics (MCRB) EBIT Margin (2016 - 2026)
Seres Therapeutics (MCRB) recorded EBIT Margin of -2890.35% in Q2 2026, up 2949.59 percentage points from the prior quarter.
Powered by 
Analysis
Seres Therapeutics (MCRB) EBIT Margin (2016 - 2026) Analysis & Trends
On a TTM basis, Seres Therapeutics' EBIT Margin came in at -4462.77% as of Jun 30, 2026; for FY2025, it came in at -11910.14%.
- Annual EBIT Margin has a five-year change of -11644.81 percentage points (FY2020 to FY2025).
- Across earlier years, EBIT Margin came in at -2524.05% in FY2022 (-2479.55 pp) and -44.50% in FY2021 (+220.83 pp).
- The Q2 2026 figure is the highest quarterly EBIT Margin since Q2 2023.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 5246.81 percentage points in Q2 2023, against a drop of 12666.35 percentage points in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -5839.94% (Q1 2026), -4423.97% (Q4 2025) and -6403.70% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 28.37% |
| 10 | Seres Therapeutics | 22.42 Mn | -116.41 Mn | - | -2,890.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,890.35% |
| Mar 31, 2026 | -5,839.94% |
| Dec 31, 2025 | -4,423.97% |
| Sep 30, 2025 | -6,403.70% |
| Sep 30, 2023 | -14,382.58% |
| Jun 30, 2023 | 39.16% |
| Mar 31, 2023 | -13,518.77% |
| Dec 31, 2022 | -177.54% |
| Sep 30, 2022 | -1,716.23% |
| Jun 30, 2022 | -5,207.65% |
| Mar 31, 2022 | -3,734.16% |
| Dec 31, 2021 | -684.56% |
| Sep 30, 2021 | 53.98% |
| Jun 30, 2021 | -914.73% |
| Mar 31, 2021 | -617.80% |
| Dec 31, 2020 | -101.90% |
| Sep 30, 2020 | -2,116.80% |
| Jun 30, 2020 | -339.87% |
| Mar 31, 2020 | -240.47% |
| Dec 31, 2019 | -251.80% |
API Access
Seres Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=MCRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();